This study demonstrates improved nucleic acid delivery using solid lipid nanoparticles, highlighting an optimal lipid balance.
This study presents the development of PEGylated solid lipid nanoparticles with an optimally balanced ionizable/cationic lipid content as an efficient and nontoxic delivery vehicle for diverse nucleic acid cargoes.
No takes yet. Share an insight, caveat, or question.
Maniyamgama et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: